Led by Christina Reh, MD, the TrialNet team at UCLA is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, UCLA is regionally overseen by University of California - San Fransisco. If you reach out to TrialNet, you may be contacted by staff from either institution.